经口激光显微手术治疗局部晚期喉癌:前/后间隙受累的预后影响
多因素分析显示切缘阳性及前、后声门旁间隙侵犯是局部控制下降的独立因素,前、后声门旁间隙受累也是全喉切除的独立因素。5年总生存率63.9%、疾病特异性生存率77.5%、无喉切除生存率77.5%。
要点
- 前、后声门旁间隙侵犯是经口激光术后局部控制下降的独立危险因素
- 前、后声门旁间隙受累也是需行全喉切除的独立预测因素
- 后声门旁间隙受累患者5年无喉切除生存率降低
核心结论
- 按喉部间隙分类的肿瘤分期与经口激光显微手术后的局部控制和无喉切除生存率强相关。
主要发现
- 杓状软骨固定的肿瘤局部控制率最低。
- 多因素分析中切缘阳性(HR=0.289 [0.085-0.979])、前声门旁间隙侵犯(HR=0.278 [0.128-0.605])和后声门旁间隙侵犯(HR=0.269 [0.115-0.630])是局部控制下降的独立因素。
- 前声门旁间隙(HR=3.613 [1.537-8.495])和后声门旁间隙(HR=5.195 [2.167-12.455])受累是全喉切除的独立因素。
- 5年总生存率、疾病特异性生存率和无喉切除生存率分别为63.9%、77.5%和77.5%。
- 后声门旁间隙受累患者5年无喉切除生存率降低。
临床怎么用
- 对T3-T4a喉癌行经口激光显微手术前应评估声门旁间隙受累情况以预判局部控制和无喉切除生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate the importance of larynx compartments in the prognosis of T3-T4a laryngeal cancer treated with transoral laser microsurgery. METHODS: Two hundred and two consecutive pT3-T4a larynx carcinomas. Pre-epiglottic space involvement, anterior and posterior paraglottic space (PGS) involvement, vocal cord, and arytenoid mobility were determined. Local control with laser (LC), overall survival (OS), disease-specific survival (DSS), and laryngectomy-free survival (LFS) were evaluated. RESULTS: The lowest LC was found in tumors with fixed arytenoid. In the multivariate analysis, positive margins (hazard ratio [HR] = 0.289 [0.085-0.979]) and anterior (HR = 0.278 [0.128-0.605]) and posterior (HR = 0.269 [0.115-0.630]) PGS invasion were independent factors of a reduced LC. Anterior (HR = 3.613 [1.537-8.495]) and posterior (HR = 5.195 [2.167-12.455]) PGS involvement were independent factors of total laryngectomy. Five-year OS, DSS, and LFS rates were 63.9%, 77.5%, and 77.5%, respectively. Patients with posterior PGS presented a reduced 5-year LFS. CONCLUSIONS: Tumor classification according to laryngeal compartmentalization depicts strong correlation with LC and LFS.
引用
- Vilaseca I, Aviles-Jurado FX, Valduvieco I, et al. Transoral laser microsurgery in locally advanced laryngeal cancer: Prognostic impact of anterior versus posterior compartments. Head Neck. 2021. PMID: 34569120. doi:10.1002/hed.26878
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。